Concepedia

Songkai Yan

SY

21

Publications

2.2K

Citations

18

H-Index

1999

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

CSL (United States)

Western University

Hospital of the University of Pennsylvania

RTI Health Solutions

Songkai Yan is an author at GlaxoSmithKline (United States) specializing in medicine, outcomes research, and health economics.

ORCID

Top concepts

Publications per year

1999–2022

21

Publications

21

Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn’s disease

Gary R. Lichtenstein, Songkai Yan, Mohan Bala et al. · Gastroenterology · 2005 · 593 citations · Full text

, , +3

Remission in Patients with Crohn's Disease is Associated with Improvement in Employment and Quality of Life and a Decrease in Hospitalizations and Surgeries

Gary R. Lichtenstein, Songkai Yan, Mohan Bala et al. · The American Journal of Gastroenterology · 2004 · 263 citations

Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study

Jürgen Braun, Robert B M Landewé, Kay‐Geert Hermann et al. · Arthritis & Rheumatism · 2006 · 242 citations

Impact of Irritable Bowel Syndrome on Quality of Life and Resource Use in the United States and United Kingdom

Beth Hahn, Songkai Yan, Scott A. Strassels · Digestion · 1999 · 234 citations

The Effects of Infliximab Therapy on Health-Related Quality of Life in Ulcerative Colitis Patients

Brian G. Feagan, Walter Reinisch, Paul Rutgeerts et al. · The American Journal of Gastroenterology · 2007 · 178 citations

Rows per page

1–5 of 21